The irony of patient centricity is its name – that a movement designed to help people look after their own health is described in terms that disempower.
There are between 6000 and 8000 rare diseases in the world, and one in ten people in Europe and the US have a rare disease; 75% of rare diseases affect children, and 30% of rare disease patients di
Merck KGaA, Darmstadt, Germany’s Lynn Taylor talked to pharmaphorum about the challenges facing the government affairs and policy function, from pricing challenges, to the reputation of pharma,